ARCHIVES

More Bad News for AVEO As Tivozanib Partner Bids Adieu

This article is from The Cancer Letter archive.

Vol. 39 No. 22 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Advisers Discuss What To Do About Physician-Scientists

May 1, 1992

Cell Genesys Begins Phase II Trial Of Gvax Vaccine For Pancreatic Cancer.

November 30, 2001

Three Studies Demonstrate Oncotype DX Test Effectiveness

March 30, 2012

Intarferon Results Promising, ACS Says, And commits Another $3.4 Million

February 22, 1980

ASC Survey Leads to Strategic Plan Development, Office In Washington

June 9, 1989

Jill ElkenberryTo Get ACCC Award

March 17, 1989